Journal of ethnopharmacology
Cure8 research brief
Why This Matters
People with UC or IBD may be interested because the study identifies plant-derived compounds that reduce inflammation in lab models of ulcerative colitis and points to molecular pathways relevant to IBD.
Who Should Pay Attention
Researchers studying IBD drug discovery, translational scientists, and clinicians interested in emerging preclinical findings on anti‑inflammatory natural products.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study combines an experimental colitis model (DSS mice), chemical isolation, serum pharmacochemistry (LC‑MS), in vitro anti‑inflammatory screening (NO production in RAW264.7 cells), network pharmacology predictions, and Western blots to validate signaling effects.
The work is preclinical mechanistic research identifying candidate anti‑UC compounds rather than clinical evidence of benefit in people. The findings suggest flavonoid C‑glycosides from O. caudata leaves as candidate lead compounds that may modulate TNF‑mediated MAPK and PI3K–AKT pathways, supporting further drug‑discovery or translational studies.
This summary is grounded in the journal abstract provided and does not reflect review of the full published paper beyond that abstract.
Keep In Mind
This is preclinical research (mouse model and cell studies) reported in an academic journal abstract; it does not provide evidence that O. caudata or its compounds are safe or effective treatments in humans. Further pharmacology, toxicology, and clinical trials would be needed.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of ethnopharmacology
AuthorsJingya Ruan, Qianqian Zhang, Qianqian Geng +5 more
InstitutionTianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, 301617 Tianjin, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 26, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors have used DeepSeek for language polishing of this manuscript.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells
The study suggests a new mechanism—blocking HSP90-mediated necroptosis of intestinal epithelial cells—that may reduce inflammation and tissue damage in ulcerative colitis, which could guide early drug-discovery efforts.
Poricoic acid a ameliorates ulcerative colitis via AMPK/PPARγ pathway-dependent cellular senescence inhibition and concomitant gut microbiota-metabolome modulation.
This study identifies a plant-derived compound (poricoic acid A) that reduced inflammation, cellular senescence, and colon injury in cell and mouse models of ulcerative colitis and links those effects to AMPK/PPARγ...
Anti-Inflammatory Components of Artemisia scoparia Alleviate Ulcerative Colitis: An Integrated Study Combining UPLC-Q-Exactive Orbitrap MS/MS, Network Pharmacology, Molecular Docking, and In Vivo/In Vitro Validation
The study identifies specific anti-inflammatory compounds in Artemisia scoparia and shows they reduce inflammation in cell and mouse models of ulcerative colitis, suggesting potential new leads for drug or...